CoChat

A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans

Open access

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 23 of the 30 sources its claims cite were checked for support.

Abstract

Core members of a conserved histone deacetylase complex are needed for proper biofilm formation, including dispersal of cells from biofilms and multifactorial drug resistance.

Overview

CoChat Summary

TL;DR

The core Set3 histone deacetylase complex subunits Set3, Hos2, Snt1, and Sif2 are required for normal Candida albicans biofilm dispersal and biofilm-specific drug resistance. Deleting any core subunit produces hypercohesive, rubbery biofilms with increased biomass, impaired dispersal, and increased resistance to multiple antifungals, while planktonic drug susceptibility remains unchanged.

Key findings

  • All four core Set3 complex mutants (hos2Δ/Δ, sif2Δ/Δ, snt1Δ/Δ, set3Δ/Δ) formed biofilms with significantly increased dry-weight biomass versus wild type: P = 0.01 for hos2Δ/Δ, P = 0.02 for sif2Δ/Δ, P = 0.01 for snt1Δ/Δ, and P = 0.04 for set3Δ/Δ.
  • Mutant biofilms were physically distinct: they remained intact after pipette agitation, whereas wild-type biofilms broke apart; in a rat catheter model, hos2Δ/Δ and set3Δ/Δ biofilms were exceptionally sticky.
  • All four mutants were significantly defective in both standard and sustained biofilm dispersal assays at every time point examined (P < 0.005), while the nrg1Δ/Δ reference was also dispersal-defective (P < 0.002).
  • Biofilms of all four mutants were significantly more resistant than wild type to 1,10-phenanthroline, 4-nitroquinoline N-oxide, caspofungin acetate, and amphotericin B (P < 0.05 each); planktonic MIC assays showed similar drug susceptibility to wild type, and no significant changes were detected in CDR1, CDR2, CDR3, membrane permeability, or matrix β-1,3-glucan.

Methods

  • Used four constructed C. albicans core Set3 complex homozygous deletion mutants (hos2Δ/Δ, sif2Δ/Δ, snt1Δ/Δ, set3Δ/Δ), wild-type references, and an nrg1Δ/Δ dispersal reference; biofilms were grown under standard in vitro conditions and, for a subset, in an in vivo rat central venous catheter model.
  • Phenotypes were assessed by visual perturbation assay, dry-weight biomass, crystal violet staining, confocal scanning laser microscopy, scanning electron microscopy, standard and sustained biofilm dispersal assays, planktonic MIC assays, 96-well biofilm drug disruption assays, CFU and XTT viability assays, qPCR for efflux pumps, FDA membrane permeability assay, and matrix β-1,3-glucan measurement.
  • Statistical significance was calculated with Student’s one-tailed paired t test; many assays used five replicate wells or five independent samples per strain.

Limitations

  • The paper states that add-back strains were not tested in vivo to minimize the number of animals used, and that it cannot rule out the possibility that loss of Set3 complex members alters expression of other unknown genes with effects on virulence.
  • The paper states that the XTT assay showed high day-to-day variation for the Set3 complex mutants, so the authors consider the quantitative biofilm CFU viability assay more accurate.
  • Evident from the text: only two mutants (hos2Δ/Δ and set3Δ/Δ) were tested in the in vivo rat catheter model, and the specific physical or molecular basis for the increased biofilm drug resistance was not identified, although efflux pumps, membrane integrity, and β-1,3-glucan were ruled out.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/mbio.01201-14

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIG 1 Phenotypic characterization of the biofilms formed by Set3 complex mutants. The top row shows the visual appearance of the biofilm perturbation assays for the wild type (A) and the hos2Δ/Δ (B), sif2Δ/Δ (C), snt1Δ/Δ (D), and set3Δ/Δ (E) mutants. the middle and bottom rows show top (F to J)- and side (K to O)-view CSLM images of the wild-type and Set3 complex mutant strains after 24 h of growth. Scale bars represent 50 µm.
FIG 1 Phenotypic characterization of the biofilms formed by Set3 complex mutants. The top row shows the visual appearance of the biofilm perturbation assays for the wild type (A) and the hos2Δ/Δ (B), sif2Δ/Δ (C), snt1Δ/Δ (D), and set3Δ/Δ (E) mutants. the middle and bottom rows show top (F to J)- and side (K to O)-view CSLM images of the wild-type and Set3 complex mutant strains after 24 h of growth. Scale bars represent 50 µm.CC BY-NC-SA · PubMed Central
FIG 2 Biofilm biomass of Set3 complex mutants. The average total biomass ± the standard deviation for each Set3 complex mutant strain grown under standard biofilm conditions was calculated from five independent samples of each strain. Statistical significance (P values) was calculated with Student’s one-tailed paired t test and is represented by the red star indicating the four Set3 complex mutant strains (hos2Δ/Δ, sif2Δ/Δ, snt1Δ/Δ, and set3Δ/Δ) with biomasses significantly differing (P < 0.05) from that of the wild-type (WT) reference strain.
FIG 2 Biofilm biomass of Set3 complex mutants. The average total biomass ± the standard deviation for each Set3 complex mutant strain grown under standard biofilm conditions was calculated from five independent samples of each strain. Statistical significance (P values) was calculated with Student’s one-tailed paired t test and is represented by the red star indicating the four Set3 complex mutant strains (hos2Δ/Δ, sif2Δ/Δ, snt1Δ/Δ, and set3Δ/Δ) with biomasses significantly differing (P < 0.05) from that of the wild-type (WT) reference strain.CC BY-NC-SA · PubMed Central
FIG 3 Biofilm formation of Set3 complex mutants in a rat catheter in vivo model. Wild-type reference strain SN425 (A and D) and Set3 complex mutant strains CJN2775 (snt1Δ/Δ) and CJN2770 (set3Δ/Δ) (B, C, E, and F) were inoculated into rat intravenous catheters, and the resulting biofilms were visualized after 24 h of growth by SEM. These SEM images show catheter luminal surfaces at high (A to C) and low (D to F) magnifications. Scale bars represent 20 µm in high-magnification images and 200 µm in low-magnification images.
FIG 3 Biofilm formation of Set3 complex mutants in a rat catheter in vivo model. Wild-type reference strain SN425 (A and D) and Set3 complex mutant strains CJN2775 (snt1Δ/Δ) and CJN2770 (set3Δ/Δ) (B, C, E, and F) were inoculated into rat intravenous catheters, and the resulting biofilms were visualized after 24 h of growth by SEM. These SEM images show catheter luminal surfaces at high (A to C) and low (D to F) magnifications. Scale bars represent 20 µm in high-magnification images and 200 µm in low-magnification images.CC BY-NC-SA · PubMed Central
FIG 4 Biofilm dispersal assays of Set3 complex mutants. Standard-dispersal (A·to C) and sustained-dispersal (D to F) assays at three time points (24, 48, and 60 h) are shown. Five replicate wells were used for each strain.
FIG 4 Biofilm dispersal assays of Set3 complex mutants. Standard-dispersal (A·to C) and sustained-dispersal (D to F) assays at three time points (24, 48, and 60 h) are shown. Five replicate wells were used for each strain.CC BY-NC-SA · PubMed Central
FIG 5 Planktonic drug MIC assays. For planktonic MIC assays, 1,10-phenanthroline was tested at concentrations of 160 µg/ml down to 0 µg/ml in 2-fold dilution steps (A), 4-nitroquinoline N-oxide was tested at concentrations of 2 µg/ml down to 0 µg/ml in 2-fold dilution steps (B), caspofungin acetate was tested at 100 µg/ml down to 0 µg/ml in various dilution steps (C), and amphotericin B was tested at 5 µg/ml down to 0 µg/ml in 2-fold dilution steps (D). MIC assays were performed in triplicate. Mean OD600 readings are reported with standard errors. BF Sup, biofilm supernatant; WT, wild type.
FIG 5 Planktonic drug MIC assays. For planktonic MIC assays, 1,10-phenanthroline was tested at concentrations of 160 µg/ml down to 0 µg/ml in 2-fold dilution steps (A), 4-nitroquinoline N-oxide was tested at concentrations of 2 µg/ml down to 0 µg/ml in 2-fold dilution steps (B), caspofungin acetate was tested at 100 µg/ml down to 0 µg/ml in various dilution steps (C), and amphotericin B was tested at 5 µg/ml down to 0 µg/ml in 2-fold dilution steps (D). MIC assays were performed in triplicate. Mean OD600 readings are reported with standard errors. BF Sup, biofilm supernatant; WT, wild type.CC BY-NC-SA · PubMed Central
FIG 6 Drug biofilm disruption assays. In biofilm disruption assays, 1,10-phenanthroline was tested at a concentration of 160 µg/ml (A), 4-nitroquinoline N-oxide was tested at a concentration of 2 µg/ml (B), caspofungin acetate was tested at a concentration of 100 µg/ml (C), and amphotericin B was tested at a concentration of 50 µg/ml (D). Fold changes in the with/without drug treatment ratios of the OD600 values of mutants relative to the wild-type (WT) OD600 ratio are shown, and the wild-type OD600 ratio was set to 1.0. Five replicate wells were used for each condition. Statistical significance (P values) was calculated with Student’s one-tailed paired t test and is represented by red stars indicating the four Set3 complex mutant strains (hos2Δ/Δ, sif2Δ/Δ, snt1Δ/Δ, and set3Δ/Δ) with OD600 values significantly differing (P < 0.05) from that of the wild-type reference strain.
FIG 6 Drug biofilm disruption assays. In biofilm disruption assays, 1,10-phenanthroline was tested at a concentration of 160 µg/ml (A), 4-nitroquinoline N-oxide was tested at a concentration of 2 µg/ml (B), caspofungin acetate was tested at a concentration of 100 µg/ml (C), and amphotericin B was tested at a concentration of 50 µg/ml (D). Fold changes in the with/without drug treatment ratios of the OD600 values of mutants relative to the wild-type (WT) OD600 ratio are shown, and the wild-type OD600 ratio was set to 1.0. Five replicate wells were used for each condition. Statistical significance (P values) was calculated with Student’s one-tailed paired t test and is represented by red stars indicating the four Set3 complex mutant strains (hos2Δ/Δ, sif2Δ/Δ, snt1Δ/Δ, and set3Δ/Δ) with OD600 values significantly differing (P < 0.05) from that of the wild-type reference strain.CC BY-NC-SA · PubMed Central
FIG 7 Biofilm cell viability CFU assays. The viable biofilm cell burden was determined after drug treatment by physical disruption of the biofilm remaining at the bottom of the well, followed by serial dilutions, plating, and CFU counting. The average of four dilutions from five wells is shown. Fold changes in the with/without drug treatment ratios of the CFU counts of mutants relative to the wild-type (WT) CFU count ratio are shown, and the wild-type CFU count ratio was set to 1.0. Statistical significance (P values) was calculated with Student’s one-tailed paired t test and is represented by red stars indicating the four Set3 complex mutant strains (hos2Δ/Δ, sif2Δ/Δ, snt1Δ/Δ, and set3Δ/Δ) with CFU counts significantly differing (P < 0.05) from that of the wild-type reference strain.
FIG 7 Biofilm cell viability CFU assays. The viable biofilm cell burden was determined after drug treatment by physical disruption of the biofilm remaining at the bottom of the well, followed by serial dilutions, plating, and CFU counting. The average of four dilutions from five wells is shown. Fold changes in the with/without drug treatment ratios of the CFU counts of mutants relative to the wild-type (WT) CFU count ratio are shown, and the wild-type CFU count ratio was set to 1.0. Statistical significance (P values) was calculated with Student’s one-tailed paired t test and is represented by red stars indicating the four Set3 complex mutant strains (hos2Δ/Δ, sif2Δ/Δ, snt1Δ/Δ, and set3Δ/Δ) with CFU counts significantly differing (P < 0.05) from that of the wild-type reference strain.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

16 Valid · 1 Not valid · 5 Not checked · 40 Own results and interpretations

32 more claims · 3 with their cited sources checked

Create a free account to see all 62 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 14
  • Probably not a substantial claim. 14

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 56 references

Cited by

See all 87

Metadata

Authors
Nobile, C. J., Fox, E. P., Hartooni, N., Mitchell, K. F., Hnisz, D., Andes, D. R., Kuchler, K., & Johnson, A. D.
Affiliations
  • University of California, Merced (US)
  • University of California, San Francisco (US)
  • University of Wisconsin–Madison (US)
  • Max Perutz Labs (AT)
Corresponding author
Nobile, Clarissa J.
Venue
mBio
Published
2014-07
Volume
5
Issue
3
Pages
e01201-14
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2123140871
Cited by
87
References
56
Citations by year
2026: 7 · 2025: 5 · 2024: 5 · 2023: 9 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 10 · 2015: 9 · 2014: 1
FWCI
6.54
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Austrian Science Fund (FWF-P25333-B22)
  • National Institutes of Health
  • University of California, San Francisco
  • National Institute of General Medical Sciences (T32GM007810)
  • National Institute of Allergy and Infectious Diseases (K99AI100896, R01AI083311, R01AI073289, T32AI060537)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Keywords
Candida albicans, biofilm dispersal, histone deacetylase complex, Hos2, silicon difluoride, antifungal resistance, biofilm formation, fungal pathogens
MeSH terms
Antifungal Agents, Candida albicans, Candidiasis, Fungal Proteins, Histone Deacetylases, Humans, Microbial Sensitivity Tests, Fluconazole, Gene Expression Regulation, Fungal, Biofilms, Drug Resistance, Fungal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans. https://app.cochat.ai/papers/10.1128/mbio.01201-14
The paper
Nobile, C. J., Fox, E. P., Hartooni, N., Mitchell, K. F., Hnisz, D., Andes, D. R., Kuchler, K., & Johnson, A. D. (2014). A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans. mBio. https://doi.org/10.1128/mbio.01201-14

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.